Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane

  • Technology appraisal guidance
  • TA458
  • Published: 
  • Last updated: 
Download guidance (PDF)

Update information

November 2017: Reference to a commercial access agreement in recommendation 1.1 has been replaced with details of a patient access scheme. Sections 2 and 5.4 have been updated with the same information.

ISBN: 978-1-4731-2595-7